Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells.

Glorieux C, Sandoval JM, Dejeans N, Nonckreman S, Bahloula K, Poirel HA, Calderon PB.

Oxid Med Cell Longev. 2018 Jan 28;2018:5351967. doi: 10.1155/2018/5351967. eCollection 2018.

2.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

3.

Control of the Unfolded Protein Response in Health and Disease.

Doultsinos D, Avril T, Lhomond S, Dejeans N, Guédat P, Chevet E.

SLAS Discov. 2017 Aug;22(7):787-800. doi: 10.1177/2472555217701685. Epub 2017 Apr 28.

PMID:
28453376
4.

Chromatin remodeling regulates catalase expression during cancer cells adaptation to chronic oxidative stress.

Glorieux C, Sandoval JM, Fattaccioli A, Dejeans N, Garbe JC, Dieu M, Verrax J, Renard P, Huang P, Calderon PB.

Free Radic Biol Med. 2016 Oct;99:436-450. doi: 10.1016/j.freeradbiomed.2016.08.031. Epub 2016 Aug 31.

PMID:
27591797
5.

Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.

Glorieux C, Sandoval JM, Dejeans N, Ameye G, Poirel HA, Verrax J, Calderon PB.

Life Sci. 2016 Jan 15;145:57-65. doi: 10.1016/j.lfs.2015.12.017. Epub 2015 Dec 10.

PMID:
26687450
6.

Novel roles of the unfolded protein response in the control of tumor development and aggressiveness.

Dejeans N, Barroso K, Fernandez-Zapico ME, Samali A, Chevet E.

Semin Cancer Biol. 2015 Aug;33:67-73. doi: 10.1016/j.semcancer.2015.04.007. Epub 2015 May 5. Review.

7.

Adaptation of the secretory pathway in cancer through IRE1 signaling.

Lhomond S, Pallares N, Barroso K, Schmit K, Dejeans N, Fazli H, Taouji S, Patterson JB, Chevet E.

Methods Mol Biol. 2015;1292:177-94. doi: 10.1007/978-1-4939-2522-3_13.

PMID:
25804756
8.

AICAR induces Nrf2 activation by an AMPK-independent mechanism in hepatocarcinoma cells.

Sid B, Glorieux C, Valenzuela M, Rommelaere G, Najimi M, Dejeans N, Renard P, Verrax J, Calderon PB.

Biochem Pharmacol. 2014 Sep 15;91(2):168-80. doi: 10.1016/j.bcp.2014.07.010. Epub 2014 Jul 21.

PMID:
25058527
9.

Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway.

Glorieux C, Auquier J, Dejeans N, Sid B, Demoulin JB, Bertrand L, Verrax J, Calderon PB.

Biochem Pharmacol. 2014 May 15;89(2):217-23. doi: 10.1016/j.bcp.2014.02.025. Epub 2014 Mar 11.

PMID:
24630930
10.

Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer.

Pluquet O, Dejeans N, Chevet E.

Ann Med. 2014 Jun;46(4):233-43. doi: 10.3109/07853890.2013.874664. Epub 2014 Feb 4. Review.

PMID:
24491143
11.

Addicted to secrete - novel concepts and targets in cancer therapy.

Dejeans N, Manié S, Hetz C, Bard F, Hupp T, Agostinis P, Samali A, Chevet E.

Trends Mol Med. 2014 May;20(5):242-50. doi: 10.1016/j.molmed.2013.12.003. Epub 2014 Jan 20.

PMID:
24456621
12.

Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα.

Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M, Combe C, Loriot S, Cubel G, Dugot-Senant N, Vital A, Loiseau H, Gosline SJ, Taouji S, Hallett M, Sarkaria JN, Anderson K, Wu W, Rodriguez FJ, Rosenbaum J, Saltel F, Fernandez-Zapico ME, Chevet E.

Cancer Res. 2013 Aug 1;73(15):4732-43. doi: 10.1158/0008-5472.CAN-12-3989. Epub 2013 Jun 10.

13.

MicroRNA-1291-mediated silencing of IRE1α enhances Glypican-3 expression.

Maurel M, Dejeans N, Taouji S, Chevet E, Grosset CF.

RNA. 2013 Jun;19(6):778-88. doi: 10.1261/rna.036483.112. Epub 2013 Apr 18.

14.

Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif.

Beck R, Dejeans N, Glorieux C, Creton M, Delaive E, Dieu M, Raes M, Levêque P, Gallez B, Depuydt M, Collet JF, Calderon PB, Verrax J.

PLoS One. 2012;7(7):e40795. doi: 10.1371/journal.pone.0040795. Epub 2012 Jul 27.

15.

Effect of a high-fat challenge on the proteome of human postprandial plasma.

Dejeans N, Herosimczyk A, Sayd T, Chambon C, Martin JF, Maier JA, Tauveron I, Mazur A.

Clin Nutr. 2013 Jun;32(3):468-71. doi: 10.1016/j.clnu.2012.05.017. Epub 2012 Jun 19.

PMID:
22721722
16.

Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA.

Dejeans N, Pluquet O, Lhomond S, Grise F, Bouchecareilh M, Juin A, Meynard-Cadars M, Bidaud-Meynard A, Gentil C, Moreau V, Saltel F, Chevet E.

J Cell Sci. 2012 Sep 15;125(Pt 18):4278-87. doi: 10.1242/jcs.099291. Epub 2012 Jun 20.

17.

Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence.

Dejeans N, Glorieux C, Guenin S, Beck R, Sid B, Rousseau R, Bisig B, Delvenne P, Buc Calderon P, Verrax J.

Free Radic Biol Med. 2012 Mar 15;52(6):993-1002. doi: 10.1016/j.freeradbiomed.2011.12.019. Epub 2012 Jan 2.

PMID:
22245095
18.

Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets.

Pachikian BD, Essaghir A, Demoulin JB, Neyrinck AM, Catry E, De Backer FC, Dejeans N, Dewulf EM, Sohet FM, Portois L, Deldicque L, Molendi-Coste O, Leclercq IA, Francaux M, Carpentier YA, Foufelle F, Muccioli GG, Cani PD, Delzenne NM.

PLoS One. 2011;6(8):e23365. doi: 10.1371/journal.pone.0023365. Epub 2011 Aug 10.

19.

Intracellular ATP levels determine cell death fate of cancer cells exposed to both standard and redox chemotherapeutic agents.

Verrax J, Dejeans N, Sid B, Glorieux C, Calderon PB.

Biochem Pharmacol. 2011 Dec 1;82(11):1540-8. doi: 10.1016/j.bcp.2011.07.102. Epub 2011 Aug 9.

PMID:
21843513
20.

Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy.

Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J.

Biochem Pharmacol. 2011 Nov 15;82(10):1384-90. doi: 10.1016/j.bcp.2011.06.007. Epub 2011 Jun 13.

PMID:
21689642
21.

Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies.

Beck R, Dejeans N, Glorieux C, Pedrosa RC, Vásquez D, Valderrama JA, Calderon PB, Verrax J.

Curr Med Chem. 2011;18(18):2816-25. Review.

PMID:
21568884
22.

Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress.

Verrax J, Beck R, Dejeans N, Glorieux C, Sid B, Pedrosa RC, Benites J, Vásquez D, Valderrama JA, Calderon PB.

Anticancer Agents Med Chem. 2011 Feb;11(2):213-21. Review.

PMID:
21395522
23.

Modulation of gene expression in endothelial cells by hyperlipaemic postprandial serum from healthy volunteers.

Dejeans N, Maier JA, Tauveron I, Milenkovic D, Mazur A.

Genes Nutr. 2010 Sep;5(3):263-74. doi: 10.1007/s12263-010-0166-x. Epub 2010 Feb 2.

24.

Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study.

Beck R, Pedrosa RC, Dejeans N, Glorieux C, Levêque P, Gallez B, Taper H, Eeckhoudt S, Knoops L, Calderon PB, Verrax J.

Invest New Drugs. 2011 Oct;29(5):891-900. doi: 10.1007/s10637-010-9441-3. Epub 2010 May 8.

PMID:
20454833
25.

Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells.

Dejeans N, Tajeddine N, Beck R, Verrax J, Taper H, Gailly P, Calderon PB.

Biochem Pharmacol. 2010 May 1;79(9):1221-30. doi: 10.1016/j.bcp.2009.12.009. Epub 2009 Dec 16.

PMID:
20006589
26.

Transcriptomic analysis of aorta from a short-term high-fat diet fed mouse reveals changes in the expression of vessel structure genes.

Dejeans N, Auclair S, Chauvet S, Milenkovic D, Mazur A.

J Physiol Pharmacol. 2009 May;60 Suppl 1:37-45.

PMID:
19609012
27.

Menadione reduction by pharmacological doses of ascorbate induces an oxidative stress that kills breast cancer cells.

Beck R, Verrax J, Dejeans N, Taper H, Calderon PB.

Int J Toxicol. 2009 Jan-Feb;28(1):33-42. doi: 10.1177/1091581809333139.

PMID:
19482829
28.

In situ modulation of oxidative stress: a novel and efficient strategy to kill cancer cells.

Verrax J, Pedrosa RC, Beck R, Dejeans N, Taper H, Calderon PB.

Curr Med Chem. 2009;16(15):1821-30. Review.

PMID:
19442148
29.

A specialized cDNA microarray (Mouse Lipid Chip) reveals hepatic overexpression of serum amyloid a in high-fat diet-fed mice.

Dejeans N, Auclair S, Henry-Berger J, Lobaccaro JM, Mazur A.

Horm Metab Res. 2008 Mar;40(3):228-30. doi: 10.1055/s-2008-1046797. No abstract available.

PMID:
18348084
30.

Plasma proteome analysis: 2D gels and chips.

Herosimczyk A, Dejeans N, Sayd T, Ozgo M, Skrzypczak WF, Mazur A.

J Physiol Pharmacol. 2006 Nov;57 Suppl 7:81-93. Review.

Supplemental Content

Loading ...
Support Center